Compass Pathways PLC CMPS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/20/22 EDT
8.36UNCH (UNCH)
Volume
2,289
Close
8.36quote price arrow up+0.01 (+0.12%)
Volume
330,610
52 week range
6.54 - 49.52
Loading...
  • Open8.56
  • Day High8.72
  • Day Low7.95
  • Prev Close8.35
  • 52 Week High49.52
  • 52 Week High Date11/08/21
  • 52 Week Low6.54
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap355.38M
  • Shares Out42.51M
  • 10 Day Average Volume0.48M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-62.17

KEY STATS

  • Open8.56
  • Day High8.72
  • Day Low7.95
  • Prev Close8.35
  • 52 Week High49.52
  • 52 Week High Date11/08/21
  • 52 Week Low6.54
  • 52 Week Low Date05/12/22
  • Market Cap355.38M
  • Shares Out42.51M
  • 10 Day Average Volume0.48M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-62.17

RATIOS/PROFITABILITY

  • EPS (TTM)-1.94
  • P/E (TTM)-4.32
  • Fwd P/E (NTM)-3.16
  • EBITDA (TTM)-84.758M
  • ROE (TTM)-35.80%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/11/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Compass Pathways PLC

There is no recent news for this security.

Profile

MORE
COMPASS Pathways plc is a mental health care company, which is focused on developing treatments for people suffering with mental health challenges. The Company is focused on treatment-resistant depression (TRD). It is developing COMP360, a psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. Its COMP360 psilocybin therapy comprises administration of its COMP360 with psychological support from...
Address
3Rd Floor, 1 Ashley Road, Altrincham
Altrincham
WA14 2DT
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
BTAI
BioXcel Therapeutics Inc
13.57+0.33+2.49%
AKRO
Akero Therapeutics Inc
8.97-0.01-0.11%
AVTE
Aerovate Therapeutics Inc
13.16+0.39+3.05%
FMTX
Forma Therapeutics Holdings Inc
6.00+0.15+2.56%
ATHA
Athira Pharma Inc
8.93+0.68+8.24%